Skip to main content

Xylocaine

NDC 63323-481 · Fresenius Kabi USA, LLC

Generic nameLIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE
Dosage formINJECTION, SOLUTION
RouteINFILTRATION, PERINEURAL
Active ingredient(s)LIDOCAINE HYDROCHLORIDE ANHYDROUS, EPINEPHRINE BITARTRATE
Strength.005; 5 mg/mL; mg/mL
Pharmacologic classAdrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]
Marketing categoryNDA

Packages

63323-481-57 — 25 VIAL, MULTI-DOSE in 1 TRAY (63323-481-57) / 50 mL in 1 VIAL, MULTI-DOSE (63323-481-01)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

51662-1654 — lidocaine hydrochloride, 52261-0801 — Lidocaine Hydrochloride, 55550-521 — Benzalkonium Chloride, Lidocaine Hydrochloride Anhydrous, 62135-712 — Lidocaine Hydrochloride, 62135-871 — Lidocaine Hydrochloride, 63323-460 — BUPIVACAINE HYDROCHLORIDE and EPINEPHRINE BITARTRATE, 63323-461 — BUPIVACAINE HYDROCHLORIDE and EPINEPHRINE BITARTRATE, 63323-462 — BUPIVACAINE HYDROCHLORIDE and EPINEPHRINE BITARTRATE, 63323-463 — BUPIVACAINE HYDROCHLORIDE and EPINEPHRINE BITARTRATE, 63323-468 — BUPIVACAINE HYDROCHLORIDE and EPINEPHRINE BITARTRATE, 63323-482 — LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE, 63323-483 — LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE, 63323-484 — LIDOCAINE HYDROCHLORIDE, 63323-485 — LIDOCAINE HYDROCHLORIDE, 63323-486 — LIDOCAINE HYDROCHLORIDE, 63323-487 — LIDOCAINE HYDROCHLORIDE, 63323-488 — LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE, 63323-489 — LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE, 63323-491 — LIDOCAINE HYDROCHLORIDE, 63323-492 — LIDOCAINE HYDROCHLORIDE, +144 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels